Introduction {#s1}
============

Structural biology studies have provided large numbers of high-resolution proteins, often bound to small molecule ligands. The ability to predict additional ligands that will bind these proteins is an exciting opportunity for understanding drug action and repurposing. In some cases, the binding of a small molecule to a protein may explain otherwise unexpected effects of the small molecule, such as side effects of drugs. In other cases, the binding of a small molecule may suggest new uses of existing drugs, based on unexpected affinity to new targets.

Previous methods for predicting the potential binding of small molecules to protein pockets have used evolutionary, structural, biochemical and geometric properties in order to assess pocket similarity, or ligand-pocket complementarity [@pcbi.1002326-Brakoulias1], [@pcbi.1002326-Weisel1], [@pcbi.1002326-Weill1], [@pcbi.1002326-Schalon1], [@pcbi.1002326-KellenbergerE1]. For example, the method of sequence order-independent profile-profile alignment (SOIPPA) [@pcbi.1002326-Xie1] can recognize binding site similarity between the cholesteryl ester transfer protein (CETP) and off-targets, including retinoid X receptor and peroxisome proliferator-activated receptors (PPARs). These new targets may explain adverse drug effects of CETP inhibitors [@pcbi.1002326-Xie2]. SOIPPA represents binding sites with a tessellation of C-alpha atoms and characterizes binding sites using geometric similarity potentials. SOIPPA evaluates 3D alignments between binding sites that are enriched for similar angles and distances between residues. It then gauges overall similarity based on geometric criteria, evolutionary and biochemical properties.

Like SOIPPA, other methods for locally comparing binding sites typically have three steps [@pcbi.1002326-KellenbergerE1]: (1) representation of binding sites, (2) 3D alignment between two sites and (3) evaluation of a similarity metric to the two sites. Searching for the best 3D alignment is the essential step. There are geometric hashing methods (SiteEngine [@pcbi.1002326-ShulmanPeleg1] and SiteBase [@pcbi.1002326-Brakoulias1]) and methods based on clique detection (SOIPPA [@pcbi.1002326-Xie1], CavBase [@pcbi.1002326-Kuhn1] and eF-site [@pcbi.1002326-Kinoshita1]). These methods use thresholds to control the similarity of local geometries in both types of methods, but these can be difficult to set. In particular, flexible matching can be critical in achieving high performance [@pcbi.1002326-Teague1]. Thornton et al showed that binding sites with similar ligands display greater conformational variability than the corresponding ligand molecules [@pcbi.1002326-Kahraman1]. Thus, using predefined geometric models and thresholds is not optimal. Excessive reliance on crystallographic poses for both the protein and the ligand can miss potential similarities.

We have previously described the FEATURE methods for describing active sites [@pcbi.1002326-Bagley1]. In the FEATURE representation, a protein site is represented by one or more microenvironments---statistical descriptions of the occurrence of atoms, residues, secondary structures as well as biochemical and biophysical properties in radial shells around a central point [@pcbi.1002326-Wei1]. We have shown that the FEATURE representation is useful for describing sites for Ca++ binding [@pcbi.1002326-Wei1], Mg++ binding [@pcbi.1002326-Banatao1], serine protease active sites [@pcbi.1002326-Bagley1], thioredoxin active sites [@pcbi.1002326-Tang1] and others [@pcbi.1002326-Wu1]. We have also used it to evaluate the ability of engineered loops to bind ligands [@pcbi.1002326-Liu1]. In this work, we reasoned that the interactions between microenvironments in the target protein and chemical fragments in the ligand may drive molecular recognition. Because the conformational arrangement of fragments within flexible ligand molecules can be very different, we allow the corresponding microenvironments to adopt different relative geometries. We develop an algorithm, PocketFEATURE, to match microenvironments within pockets in order to find pockets with potentially similar binding capabilities.

We validate PocketFEATURE by testing its performance on two tasks. First, we test its ability to detect the similarity of binding sites that are known to bind the same (containing adenine-ribose) ligands--a test of sensitivity. Second, we test its ability to detect FAD binding across a large proteome-scale set of proteins--a test of specificity. In both tests, the method shows very strong performance, including an ability to detect similarities missed by other methods.

Kinases play an important role in cell signaling, and can be dysregulated in cancer. Several recently introduced cancer drugs act as ATP analogues and inhibit kinase action [@pcbi.1002326-Benson1],[@pcbi.1002326-Sheridan1]. Therefore, the binding capabilities (or binding profiles) of kinases may be useful for discovering novel kinase inhibitors. In particular, kinase inhibitors that bind two or more kinases in the same pathway are attractive because they can more effectively interfere with the pathway, without the need for very high doses or multiple drugs [@pcbi.1002326-Morphy1], [@pcbi.1002326-Ma1]. Kinase binding profiles may also be useful for understanding side effects of drugs that bind multiple proteins [@pcbi.1002326-Ma1]. In principle, the ability of an inhibitor to bind multiple kinases may occur despite very low sequence and structure homology. For these reasons, the ability to detect similar binding sites in divergent kinases is potentially valuable.

There are sixteen cancer drugs approved or in advanced development that are known to have multiple targets [@pcbi.1002326-Ma1]. All of these drugs target members of the same protein family that regulate the same signaling process. Accordingly, most studies have focused on dissecting the detailed binding preferences of drugs on a relatively small set of kinases that are known to be important. In fact, multi-target drugs that work on proteins within distant families are only rarely reported [@pcbi.1002326-Apsel1]. Therefore, one of the goals of this work is to discover unrecognized binding similarities between remotely related proteins to increase the repertoire of kinase inhibitor action and utility. Accordingly, we apply PocketFEATURE to predict the similarity in inhibitor-binding profiles between kinases. In particular, we seek similar inhibitor-binding profiles for kinases that are evolutionarily distant.

Results {#s2}
=======

Detecting binding site similarity {#s2a}
---------------------------------

We first validated PocketFEATURE\'s ability to detect binding site similarity. In particular, we tested its ability to recognize pockets that bind similar ligands, and distinguish them from pockets that do not bind these ligands. The benchmark dataset is provided by Bourne group from USCD [@pcbi.1002326-Xie1]. The ligands sharing similarity are: ATP, ADP, NAD, FAD, SAH and SAM, all of which contain an adenine-ribose moiety. We compared the performance of PocketFEATURE to SOIPPA, which outperforms other ligand-binding site comparison algorithms in this task [@pcbi.1002326-Xie1]. [Figure 1](#pcbi-1002326-g001){ref-type="fig"} shows PocketFEATURE\'s ability to recognize 30381 pairs of sites that both bind adenine-ribose moieties, and to recognize the lack of similarity of 24947 control pairs of sites in which one site binds adenine-ribose and the other does not. The AUC for the entire benchmark is 0.85. At specificities of 95% to 99.5%, PocketFEATURE outperforms SOIPPA. At 95% specificity, PocketFEATURE identifies about 40% similar pairs, while SOIPPA identifies less than 30%. Our results demonstrate that PocketFEATURE can identify binding sites with overlapping chemical specificity. Proteins in this test are evolutionarily divergent (\<5% of them are from the same SCOP superfamily). Thus, PocketFEATURE can detect site similarity across remote evolutionary relationships.

![Comparison of the performance of PocketFEATURE to SOIPPA.\
The benchmark measures the ability to discriminate 30381 pairs of sites that both bind adenine-ribose moieties from 24947 control pairs of sites where one site binds adenine-ribose and the other does not. The AUC for the entire benchmark is 0.85. At the specificity range of 95% to 99.5%, PocketFEATURE outperforms SOIPPA. At 95% specificity, PocketFEATURE identifies about 40% positive pairs, while SOIPPA identifies less than 30%.](pcbi.1002326.g001){#pcbi-1002326-g001}

[Figure 2](#pcbi-1002326-g002){ref-type="fig"} shows an ATP-binding site (1kvk), an NAD-binding site (1a5z) and an FAD-binding site (2b9w). There are five corresponding microenvironments in each protein (spheres are shown in [Figure 2A](#pcbi-1002326-g002){ref-type="fig"} and the types of microenvironments are listed in [Figure 2B](#pcbi-1002326-g002){ref-type="fig"}). These five microenviroments are in proximity to the adenine moiety from ATP, NAD and FAD molecules. It is important to note that the five microenvironments adopt different relative geometries in these three sample sites while coordinating the ligands. We consider the five microenvironments to constitute modules capable of recognizing adenine-ribose moieties contained within diverse ligand molecules.

![An example illustrating how PocketFEATURE identifies similar sites that bind to ligands with overlapping chemical specificity.\
We compare an ATP-binding site (1kvk/ATP), an NAD-binding site (1a5z/NAD) and an FAD-binding site (2b9w/FAD). There are five sets of mutual aligned microenvironments between the three sites. (A) 3D structures of the binding site. The five sets of mutual aligned microenvironments are represented as colored spheres: red for microenvironment centered at residue type E(mE) or D (mD), blue for mT, green for mY, orange for mV or mI and purple for mP. The five microenviroments are close to the adenine moiety from ATP, FAD and NAD molecules. The aligned microenvironments display different relative geometries in the three sites. 3D illustrations were generated using PyMOL [@pcbi.1002326-Lill1]. (B) Index of center residues for the mutual aligned microenvironments. (C) Significance of alignments. Tc scores between the five sets of mutual aligned microenvironments are mapped to the pre-calculated PDF for a given type of microenvironment pair. The scores between ATP-binding and NAD-binding sites are marked using diamonds, those between ATP-binding and FAD-binding using circles, and those between NAD-binding and FAD-binding using squares. For each of the five sets, the S(Tc) scores fall within the p-value cutoff of 0.05.](pcbi.1002326.g002){#pcbi-1002326-g002}

The S(Tc) score captures the similarity of a pair of FEATURE microenvironments. To evaluate the significance of alignments between microenvironments, we calculated the probability distribution function (PDF) of microenvironment similarity score S(Tc) using a non-redundant dataset of 3D structures in PDB. Given each set of the mutual alignment between ATP, NAD and FAD binding sites, [Figure 2C](#pcbi-1002326-g002){ref-type="fig"} maps the three S(Tc) scores to the corresponding microenvironment types. The alignments of high significance form the basis for recognizing similarity between binding sites detected by PocketFEATURE.

Detecting FAD-binding sites in a large druggable database {#s2b}
---------------------------------------------------------

The previous test demonstrated that PocketFEATURE can *sensitively* detect similarities between adenine-ribose containing pockets. We tested PocketFEATURE\'s ability to *specifically* recognize FAD-binding sites on a structural proteome scale. The Dataset-6958 is derived from an annotated database of "druggable binding sites" from PDB called scPDB (see Method section). It includes a total of 6709 non-FAD-binding proteins and 249 FAD-binding proteins, from 43 EC-families. Using a single arbitrarily selected FAD-binding site (1nhp/FAD) as a query structure, we searched the database for all other FAD-binding sites from Dataset-6958 by pairwise comparison. [Figure 3A](#pcbi-1002326-g003){ref-type="fig"} shows the overall performance with an AUC value of 0.92. At 95% specificity, PocketFEATURE identifies about 65% sites that are known to bind FAD. At 80% specificity, PocketFEATURE identifies nearly 90% sites correctly.

![Identification of FAD-binding sites in a large druggable database.\
(A) The overall performance with an AUC value of 0.92 At 95% specificity, PocketFEATURE identified about 65% sites that are known to bind FAD. At 80% specificity, PocketFEATURE identified nearly 90% sites correctly. (B) Microenvironment alignments between two FAD-binding sites. Two sites adapt to two different ligand conformations, an elongated (1nhp) and a bent butterfly conformation (1fdr). The relative geometries arrangements of aligned microenvironments are different. (C) An illustration of the corresponding positioning of aligned microenvironments and FAD molecules. The aligned microenvironments m6L/1nhp-m67L/1fdr (red), m250W/1nhp-m248W/1fdr (orange) and m79I/1nhp-m68V/1fdr (yellow) are near the adenine moiety of FAD molecules in 1nhp and 1fdr, respectively. Near phosphate chemical groups, aligned m132R/1nhp-m77P/1fdr (pink) and m12G/1nhp-m77P/1fdr (green) are observed. Another two sets of microenvironments m159Y/1nhp-m52Y/1fdr (cyan) and m300T/1nhp-m53S/1fdr (wheat) are found close to flavin groups.](pcbi.1002326.g003){#pcbi-1002326-g003}

Of note, FAD binds proteins in two general conformations [@pcbi.1002326-Dym1]: the (1) elongated and the (2) bent butterfly conformation ([Figure 3B](#pcbi-1002326-g003){ref-type="fig"}). In the bent conformation (1nhp in [Figure 3B](#pcbi-1002326-g003){ref-type="fig"}), the AMP portion is folded back, placing the adenine and isoalloxazine rings in close proximity, whereas in the elongated conformation (1fdr in [Figure 3B](#pcbi-1002326-g003){ref-type="fig"}) the adenine ring is distant from the isoalloxazine ring. Remarkably, PocketFEATURE can detect bent butterfly FAD sites based on an elongated FAD query structure. Conversely, using a binding site with a bent butterfly FAD as a query structure, PocketFEATURE can detect elongated FAD binding sties (Supplementary Material [Figure S1](#pcbi.1002326.s001){ref-type="supplementary-material"}).

[Figure 3B and 3C](#pcbi-1002326-g003){ref-type="fig"} show the microenvironment alignments detected by PocketFEATURE. (See Method section, A microenvironment is named using the following convention: "m" followed by "residue index" and "residue type", upon which the microenvironment is centered. PDB identifier or gene name is tagged when necessary.) The aligned microenvironments m6L1nhp-m67L/1fdr (red), m250W/1nhp-m248W/1fdr (orange) and m79I/1nhp-m68V/1fdr (yellow) are near the adenine moiety of FAD in 1nhp and 1fdr, respectively. Aligned microenvironments m132R/1nhp-m77P/1fdr (pink) and m12G/1nhp-m77P/1fdr (green) are adjacent to phosphate chemical groups. Another two sets of microenvironments m159Y/1nhp-m52Y/1fdr (cyan) and m300T/1nhp-m53S/1fdr (wheat) are found near flavin groups. As might be expected, the different conformations of FAD molecules in the structures 1nhp and 1fdr lead to markedly different geometric arrangements of these aligned microenvironments. However, PocketFEATURE identifies these alignments with high significance, demonstrating the robustness of the algorithm.

Other related benchmarks {#s2c}
------------------------

We have performed three independent experiments to test PocketFEATURE\'s ability to *specifically* recognize non-adenine ligand binding sites. First, using a typical steroid-binding site (1A28 bound with progesterone) to detect all other steroid-binding sites (total 83 sites) from Dataset-6985 (Supplementary Material [Figure S2](#pcbi.1002326.s002){ref-type="supplementary-material"}). The overall AUC is 0.826. Second, we compared PocketFEATURE to a 3D shape descriptor using real spherical harmonic expansion coefficients [@pcbi.1002326-Morris1], [@pcbi.1002326-Najmanovich1]. Using their published datasets (10 sites for ATP, 10 for NAD, 10 for heme and 10 for steroids), PocketFEATURE successfully clusters the four types of sites and compares favorably with the real spherical harmonic shape descriptor (Supplementary Material [Figure S3](#pcbi.1002326.s003){ref-type="supplementary-material"}). Third, we applied PocketFEATURE to predicted off-targets for Torcetrapib from a non-redundant subset of PDB for 1200 human proteins. Supplementary material [Table S1](#pcbi.1002326.s005){ref-type="supplementary-material"} lists top ranked off-targets predictions. Xie et al [@pcbi.1002326-Xie2] published a panel of 20 off-targets for CETP inhibitors (specifically Torcetrapib) predicted by SOIPPA. These predictions have been refined and validated by docking methods and critical human curation. Comparing the 20 published off-targets by SOIPPA and the 36 predictions by PocketFEATURE, we find that seven are the same. These three tests show that PocketFEATURE effectively recognizes non-adenine ligand binding sites.

The Similarity Ensemble Approach (SEA) is a method for calculating chemoinformatics similarities between drug sets [@pcbi.1002326-Hert1]. Given two binding sites, we incorporate the similarity scores between experimentally observed ligand molecules calculated by SEA into the PocketFEATURE similarity score between the binding sites. Preliminary results suggest that combining ligand chemoinformatics and target physiochemical properties leads to strong signals for similarity detection (Supplementary Material [Figure S4](#pcbi.1002326.s004){ref-type="supplementary-material"}).

Predicting inhibitor-binding for distantly related kinases {#s2d}
----------------------------------------------------------

Having established reasonable sensitivity and specificity of PocketFEATURE, we studied ATP-binding sites in kinases, to find new targets for these inhibitors. We specifically targeted kinase proteins that are distantly related, with little detectable sequence or structural similarity, because most previous work has focused on the binding properties of closely related kinases.

We calculated the binding site similarity scores of the 6058 pairs sites in distantly related kinases using PocketFEATURE. [Figure 4](#pcbi-1002326-g004){ref-type="fig"} plots the PDF of the scores for the 6058 pairs. A small p-value suggests an increased likelihood of high binding site similarity for the pair of proteins evaluated.

![Predicting overlapping of inhibitor-binding profiles between kinases.\
The binding site similarity scores of 6058 pairs of distant kinases were fitted into normal distribution. The more negative the score, the higher level of similarity between two sites is predicted. The blue dotted line is the p-value cutoff of 0.01 for highly ranked predictions (Table 1). Of the 6058 pairs, there are 40 pairs of which experimental data are available to both kinases. Out of the 40 pairs, 11 pairs have experimental results suggesting overlap in inhibitor binding -- they are "positive-pairs". The remaining 29 pairs are "negative-pairs" that do not share ligands. The significance of the separation of positive-pairs and negative-pairs in this ranking, as evaluated by a hyper-geometric distribution has a *p-value* of 4.5e-18.](pcbi.1002326.g004){#pcbi-1002326-g004}

CHEMBL is a manually curated chemical database of bioactive molecules with drug-like properties [@pcbi.1002326-Overington1]. Our local database downloaded from CHEMBL includes binding assays between a total of 3199 protein domains and 541,137 compounds. Similarly, the Ambit panel provides high-throughput kinase selectivity profiling of 317 kinases against 37 known kinase inhibitors [@pcbi.1002326-Karaman1]. Of the 6058 pairs we evaluated, there are 40 pairs for which experimental data (from CHEMBL or Ambit) are available for both kinases. Of these pairs, 11 had experimental results suggesting high overlap in inhibitor binding---they are "positive-pairs". When we rank order the 40 pairs based on their scores, nine of the 11 positive-pairs rank first through eighth, and tenth ([Figure 4](#pcbi-1002326-g004){ref-type="fig"}). The binding site similarity scores of negative-pairs range from −1.9 to −3.6---quite separate from the positives. The significance of the separation of positive-pairs and negative-pairs in this ranking, as evaluated by a hyper-geometric distribution has a *p-value* of 4.5e-18.

Using a p-value cutoff \<0.01 from the PDF (binding site similarity score cutoff of −3.76 in [Figure 4](#pcbi-1002326-g004){ref-type="fig"}), 50 pairs of kinases are predicted to have inhibiting-profile overlapping. Nine pairs have experimental evidence suggesting overlap in inhibitor binding- these are true positives ([Table 1](#pcbi-1002326-t001){ref-type="table"}). One pair is considered false positive because although the two kinases are tested in CHEMBL, they do not share ligands using our relatively stringent cutoff ([Table 2](#pcbi-1002326-t002){ref-type="table"}). The other 40 pairs with high apparent similarity are novel predictions ([Table 3](#pcbi-1002326-t003){ref-type="table"}). Experimental evidence for these kinases pairs is not available in CHEMBL or Ambit.

10.1371/journal.pcbi.1002326.t001

###### True positives predictions.

![](pcbi.1002326.t001){#pcbi-1002326-t001-1}

  EC group      PDB ID     Gene name   PID    Binding sitesimilarity   Representativeinhibitor                    
  ----------- ----------- ----------- ------ ------------------------ ------------------------- --------- ------- --------------
  2.7.10.2     2.7.11.22     2src      3blq            SRC                      CCNT1            10\. 24   −5.85     AST-487
  2.7.10.1     2.7.11.26     2hen      1j1c           Ephb2                     GSK3B             25.63    −5.31   CHEMBL247067
  2.7.10.1     2.7.11.26     1jqh      1j1c           IGF1R                     GSK3B             27.86    −4.34   CHEMBL215803
  2.7.10.1     2.7.11.22     2hen      2cch           Ephb2                     CDK2              19.98    −4.30     AST-487
  2.7.1.153    2.7.10.2      1e8x      2src           PIK3CG                     SRC              18.26    −4.28      PP121
  2.7.10.1     2.7.11.22     1jqh      2cch           IGF1R                     CDK2              23.94    −4.25    BMS-536924
  2.7.10.1     2.7.11.24     2hen      1cm8           Ephb2                    MAPK12             26.61    −4.15     AST-487
  2.7.10.1     2.7.11.24     1jqh      1cm8           IGF1R                    MAPK12             29.36    −3.83   CHEMBL215803
  2.7.1.153    2.7.11.1      1e8x      2pvr           PIK3CG                   CSNK2A1            23.17    −3.80   CHEMBL379156

Using a p-value cutoff of 0.01, 50 pairs of kinases are predicted to share inhibitors. Nine pairs have experimental evidence suggesting overlap in inhibitor binding- these are **true positives**. The first two columns are EC groups. Kinases in one pair are from different EC groups. The PDB IDs and gene names are listed in column three to row six. The seventh column lists the percentage identity (PID) of structural alignment between two kinases in a pair. The eighth column shows the binding site similarity score of the pair. The more negative the score is, the higher the similarity level between two sites is predicted.

10.1371/journal.pcbi.1002326.t002

###### False positive predictions.

![](pcbi.1002326.t002){#pcbi-1002326-t002-2}

  EC group      PDB ID    Gene name   PID    Binding site similarity                   
  ----------- ---------- ----------- ------ ------------------------- -------- ------- -------
  2.7.1.153    2.7.12.2     1e8x      1s9j           PIK3CG            MAP2K1   28.37   −3.88

One pair is considered false positive because both kinases are linked to at least one set of experimental data from CHEMBL, but they do not share ligands using our stringent standards.

10.1371/journal.pcbi.1002326.t003

###### Novel predictions of high similarity.

![](pcbi.1002326.t003){#pcbi-1002326-t003-3}

  EC group      PDB ID     Gene name   PID    Binding sitesimilarity                    
  ----------- ----------- ----------- ------ ------------------------ --------- ------- ---------
  2.7.11.2     2.7.13.3      2e0a      3d36            PDK4            spo0ANE   28.54   −6.6061
  2.7.11.2     2.7.13.3      1jm6      3d36            Pdk2            spo0ANE   28.75   −5.4505
  2.7.1.95     2.7.11.1      1j7u      1zp9            aphA             rio1     12.55   −5.4243
  2.7.11.1     2.7.13.3      1th8      2c2a          spoIIAB           TM_0853   12.5    −5.2046
  2.7.1.100    2.7.11.1      2pyw      1csn         At1g49820           cki1     28.33   −4.9383
  2.7.1.100    2.7.11.1      2olc      1zp9            mtnK             rio1     10.24   −4.6189
  2.7.1.100    2.7.11.1      2pyw      1u5r         At1g49820           Taok2    10.71   −4.475
  2.7.1.100    2.7.11.24     2olc      1cm8            mtnK            MAPK12    10.55   −4.4283
  2.7.1.153    2.7.11.1      1e8x      1zyd           PIK3CG            GCN2     11.09   −4.4036
  2.7.10.2     2.7.11.1      2ijm      1zp9            PTK2             rio1     25.91   −4.4022
  2.7.10.1     2.7.11.1      1mqb      1zp9           EPHA2             rio1     25.76   −4.3987
  2.7.1.100    2.7.11.1      2olc      1zyd            mtnK             GCN2     13.19   −4.3499
  2.7.1.100    2.7.11.1      2pyw      3e7e         At1g49820           BUB1     28.83   −4.3048
  2.7.1.153    2.7.11.1      1e8x      1lp4           PIK3CG            ACK2     23.24   −4.2874
  2.7.1.100    2.7.11.1      2olc      3e7e            mtnK             BUB1     25.83   −4.2698
  2.7.1.95     2.7.11.1      1j7u      3e7e            aphA             BUB1     7.21    −4.2628
  2.7.1.100    2.7.11.26     2pyw      1j1c         At1g49820           GSK3B    12.26   −4.1925
  2.7.1.100    2.7.12.2      2pyw      1s9j         At1g49820          MAP2K1    27.68   −4.1752
  2.7.10.1     2.7.11.1      2hen      1q97           Ephb2             SKY1     21.35   −4.1734
  2.7.1.100    2.7.10.2      2olc      2ozo            mtnK             ZAP70    12.66   −4.1549
  2.7.1.36     2.7.12.2      1kvk      1s9j            Mvk             MAP2K1    11.07   −4.1171
  2.7.10.1     2.7.11.1      1jqh      2vwi           IGF1R             OXSR1    24.17   −4.1001
  2.7.1.100    2.7.11.24     2pyw      1cm8         At1g49820          MAPK12    10.86   −4.0862
  2.7.10.1     2.7.11.1      1pkg      1zp9            KIT              rio1     24.51   −4.077
  2.7.1.100    2.7.11.1      2pyw      1o6l         At1g49820           AKT2     29.75   −4.0536
  2.7.1.100    2.7.10.2      2pyw      2src         At1g49820            SRC     20.49   −4.0529
  2.7.1.-      2.7.11.1      2a19      1zp9            SUI2             rio1     20.29   −4.0507
  2.7.1.100    2.7.11.1      2pyw      1zyd         At1g49820           GCN2     13.19   −4.0412
  2.7.10.1     2.7.11.1      2hen      1zp9           Ephb2             rio1     14.78   −4.0407
  2.7.10.2     2.7.11.1      2src      1zp9            SRC              rio1     24.28   −4.0122
  2.7.1.95     2.7.11.1      1j7u      1tqp            aphA             rio2     14.83   −4.0018
  2.7.1.100    2.7.11.1      2olc      1u5r            mtnK             Taok2    12.82   −3.9498
  2.7.1.95     2.7.11.1      1j7u      1u5r            aphA             Taok2    19.01   −3.9436
  2.7.1.100    2.7.10.1      2pyw      1pkg         At1g49820            KIT     17.11   −3.9048
  2.7.11.4     2.7.4.22      1gkz      2bri           Bckdk             pyrH     11.08   −3.8977
  2.7.1.100    2.7.12.2      2olc      1s9j            mtnK            MAP2K1    27.68   −3.8804
  2.7.1.95     2.7.11.24     1j7u      1cm8            aphA            MAPK12    11.79   −3.8187
  2.7.1.36     2.7.10.1      1kvk      2qoc            Mvk              EPHA3    10.6    −3.8101
  2.7.1.100    2.7.10.2      2pyw      2ozo         At1g49820           ZAP70    15.23   −3.8093
  2.7.1.144    2.7.11.1      2f02      1u5r            lacC             Taok2    7.63    −3.8036

In the top 50 ranked predictions, there are 40 pairs of **novel predictions** that experimental evidence for one for both kinases is not available in CHEMBL or Ambit.

Discussion {#s3}
==========

We have presented a new algorithm for detecting ligand-binding site similarity, tested it on (1) the recognition of adenine-ribose binding ligands and (2) the recognition of FAD binding sites. We then applied it to the problem of predicting cross binding of ATP analogues inhibitors of kinases.

Summary of PocketFEATURE method {#s3a}
-------------------------------

Our method works for two reasons. First, we employ a novel microenviroment-based representation and scoring system for comparing pockets that captures the physical and chemical properties in the binding pocket, and second, we do not impose rigid geometric matching criteria on the microenvironments within the pocket. The resulting method accurately recognizes similar microenvironments, and identifies combinations of microenvironments that can interact with fragments within ligand molecules.

### Representation and similarity measure between individual microenvironments {#s3a1}

Microenvironments are represented using the FEATURE representation that captures physiochemical properties of a local subsite. The raw Tc score measures similarity between two microenvironments. However, it is difficult to compare Tc scores across pairs of microenvironments because the background similarities between different pairs are not the same. Therefore, it is necessary to normalize the Tc scores. We normalize the scores by creating a background distribution for each pair type (See Method). The normalized score S(Tc) is negative, decreases monotonically with increasing Tc, and changing most rapidly for Tc\>Tc~0~. Therefore, our method seeks microenvironment-pairs that have high similarity, given the expected background score distribution.

We aligned microenvironments from an ATP, FAD and an NAD binding site ([Figure 2](#pcbi-1002326-g002){ref-type="fig"}). Microenvironment similarity score S(Tc) of aligned ones are outliers within the PDF ([Figure 2C](#pcbi-1002326-g002){ref-type="fig"}). The aligned microenvironments constitute functional modules for ligand recognition ([Figure 2A](#pcbi-1002326-g002){ref-type="fig"}). That is, particular microenviroments are associated with the recognition of particular molecular fragments with ligands. A better (more negative) S(Tc) similarity captures this shared recognition role in different binding sites.

### Geometric flexible matching between microenvironments {#s3a2}

The combined interactions between multiple microenvironments in a target protein and molecular fragments within its ligand molecule drive molecular recognition. Because fragments can adopt different poses within a ligand molecule, the FEATURE based microenvironments in the target protein can adopt different relative geometries, as shown in [Figure 3C](#pcbi-1002326-g003){ref-type="fig"}. Some methods use geometric constraints to control local arrangements of functional modules. PocketFEATURE has relatively weak geometric requirements (only that the matching microenvironments be present within the pocket of interest). As a result, the number of possible alignments between pockets is increased, and PocketFEATURE can recognize site that bind similar ligands in different poses.

Our results with FAD-binding sites illustrate the value of geometric flexibility; FAD contains highly flexible regions between flavin and adenine. The FAD conformation and orientation varies widely across different protein families. By using PocketFEATURE, microenvironments corresponding to the same fragments within FAD are recognized even though these microenvironments adopt different local geometries according to their ligand poses ([Figure 3C](#pcbi-1002326-g003){ref-type="fig"}). These results demonstrate the value of allowing microenvironments to adopt variable orientations within pockets.

We have also assessed whether the microenvironment alignments identified by PocketFEATURE correspond to specific recognition of ligand chemical substructures. The average number of microenvironments between two ATP sites is six; while that of ADP is six, that of NAD is ten and that of FAD is twelve. The common aligned microenvironments of high frequencies for these four types of binding sites are: mD, mE, mR, mK, mS and mT, all of which are in close proximity to the common sub-fragments contained within ADP, ATP, FAD and NAD: the adenine, ribose and phosphate. Thus, these microenvironments have specific roles in recognizing particular fragments within the overall molecule. Furthermore, the additional aligned microenvironments observed in FAD and NAD sites are mW and mP, which "recognize" the phosphate, flavin or nicotinamide moieties.

In summary, PocketFEATURE is more sensitive than other state-of-the-art methods. It is suitable for application on a genome scale.

PocketFEATURE defines sites based on position of known ligand binding. For apo structures and uncharacterized sites, we can also use published patch-searching algorithms, such as CONCAVITY [@pcbi.1002326-Capra1] and PocketPicker [@pcbi.1002326-Weisel1] to define sites (on-going projects).

Application of PocketFEATURE to drug discovery {#s3b}
----------------------------------------------

Current computational studies on comparing kinase inhibitor binding sites often focus on known drug targets Tyrosine kinase (TK family, EC 2.7.10) and Serine/Threonine kinases ISTE family (EC 2.7.11). Potential similarity between divergent kinases has not been systematically explored either computationally or experimentally. For example, of the 6058 pairs of divergent kinases we compared in this work, only 40 pairs have experimental data from CHEMBL and Ambit. The literature is biased towards a few well-validated kinases. Some inhibitors may appear to be more promiscuous simply because they have been profiled more systematically.

As shown in [Figure 4](#pcbi-1002326-g004){ref-type="fig"}, PocketFEATURE identifies similar ligand binding sites across distantly related kinases. The surprisingly accurate predictions ([Table 1](#pcbi-1002326-t001){ref-type="table"}) for those that have been tested make the remaining untested predictions ([Table 3](#pcbi-1002326-t003){ref-type="table"}) with high similarity scores particular interesting.

Some of our predictions rediscover combinations of divergent kinases for multi-targeted drug design. One highly ranked prediction is the pair SRC (a Tyrosine kinase) and PIK3CG (a lipid kinase in PI3K family), which are evolutionarily distant (PID\<10%). Both kinases have been observed to bind to a similar series of inhibitors (PP121 and its derivatives) [@pcbi.1002326-Apsel1]. The PocketFEATURE binding site similarity score (−4.26) ranks high ---20th out of 6058 pairs. PocketFEATURE identifies six key microenvironments ([Figure 5](#pcbi-1002326-g005){ref-type="fig"}). One alignment matches mT338/SRC to mY867/PIK3CG, both of which reside near the typical "gate" of an ATP-binding site. The gatekeeper residue enables interactions between the deep hydrophobic pocket and ligands (adenine in ATP or pyrazolopyrimidine in inhibitor ABJ). In SRC structures, residue T338 is designated as the gatekeeper and in PIK3CG structures, residue I879 [@pcbi.1002326-Apsel1]. As PocketFEATURE does not seek alignments between polar and hydrophobic residues, it does not find a match between mT338/SRC and mI879/PIK3CG. Instead, in the PIK3CG structure, the proximal mY867/PIK3CG is aligned to mT338/SRC. Thus, PocketFEATURE detects similar binding sites from these two distant kinases. SRC activates the lipid kinases of the PI3K family, a central regulator of cell growth. Molecules that target both SRC and PIK3CG may have potent antitumor activity.

![An example of validated positive predictions.\
SRC (a Tyrosine kinase) and PIK3CG (a lipid kinase) bind to a same series of inhibitors (PP121 and its derivatives). Four related structures are available in PDB. The first row is structures of SRC bound with ANP (PDB ID: 2src) and a drug-like inhibitor (PDB ID is 3en7 and ligand PDB code is ABJ). The second row is structures of PIK3CG bound with ATP (PDB ID is1e8x) and ABJ (PDB ID is 2v4l). Between binding sites of 2src (SRC/ANP) and 1e8x (PIK3CG/ATP), PocketFEATURE aligned six pairs of microenvironments. At the position near the typical "gate" of an ATP-binding site, PocketFEATURE aligned mT338/SRC to mY867/PIK3CG (light yellow sphere). In SRC structures, the gatekeeper residue T338 enables interactions between the deep hydrophobic pocket and ligands. The original experimental study suggests the residue analogous to the gatekeeper in PIK3CG is I879 (red circle), which is the nearest microenvironment to mY867/PIK3CG. (A). 3D illustration of binding sites in SRC and PIK3CG (B). Aligned microenvironments.](pcbi.1002326.g005){#pcbi-1002326-g005}

PIK3CG is also predicted to share ligands with other kinases, including CSNK21A, MAP2K1, GCN2 and ACK2 ([Table 1](#pcbi-1002326-t001){ref-type="table"}--[](#pcbi-1002326-t002){ref-type="table"} [3](#pcbi-1002326-t003){ref-type="table"}). Of these, CSNK21A encodes a Casein kinase that is involved in Wnt signaling pathway. Casein kinase inhibitors are considered potent anti-cancer drug candidates [@pcbi.1002326-Yang1]. It is possible that drugs inhibiting both CSNK21A and PIK3CG may have synergistic anti-tumor activity. ACK2 is a homolog of CSNK21A (PID\>90%). The binding site similarity score between PIK3CG and ACK2 ranks highly---18th out of 6058 pairs.

In addition to its similarity to CSNK21A, the pocket in PIK3CG is very similar to that in MAP2K1. These proteins do not share known ligands using our stringent interpretation of CHEMBL results (see Method). However, this apparent false positive deserves further scrutiny. MAP2K1 encodes an essential kinase in mitogen-activated protein (MAP) kinase signal transduction pathway. Activation of MAP kinase pathway plays important roles in the metastasis of pancreatic cancer. Specific inhibitors have been developed to inhibit oncogenic pathways. However, activation of PI3K pathway in response to MAP2K1 inhibition through a negative feed back loop limits the efficacy [@pcbi.1002326-Mirzoeva1]. The high similarity between PIK3CG and MAP2K1 by PocketFEATURE suggest the possibility of inhibitors that target both kinases.

Other highly ranked novel predictions have some implications for side effects and drug repurposing. In [Table 3](#pcbi-1002326-t003){ref-type="table"}, there are three pairs of mammalian: {Mvk-MAP2K1}, {Mvk-EPHA3} and {1GF1R-OXSR1}. Of these kinases, MAP2K1, OXSR1 and EPHA3 are implicated in cancer. Further evaluation of these pairs may be warranted. Most of other pairs in [Table 3](#pcbi-1002326-t003){ref-type="table"} are combinations of one kinase from human (or other mammalian) and one from plant (or bacteria). It is intriguing to consider that inhibitors for plant or bacterial kinases may be useful inhibitors of mammalian proteins.

Methods {#s4}
=======

FEATURE microenvironments {#s4a}
-------------------------

Given a functional center of a residue, we use the term "microenvironment" to refer to the local, spherical region in the protein structure that may encompass residues discontinuous in sequence and structure. Specifically, we use the FEATURE system to calculate a set of 80 physicochemical properties ([Table S2](#pcbi.1002326.s006){ref-type="supplementary-material"}) [@pcbi.1002326-Wei1] collected over six concentric spherical shells (total 480 properties = 80 properties×6 shells) centered on the predefined functional center ([Table S3](#pcbi.1002326.s007){ref-type="supplementary-material"}) [@pcbi.1002326-Yoon1]. The total radius of the microenvironment is 7.5 Angstroms. A microenvironment is named using the following convention: "m" followed by "residue index" and "residue type", upon which the microenvironment is centered. PDB identifier or gene name is tagged when necessary. For example m6L/1nhp represents the microenvironment centered on the functional center of the sixth residue in 1nhp, which is leucine (L). A complete description of FEATURE can be found in the original publication.

Similarity measure between two FEATURE microenvironments {#s4b}
--------------------------------------------------------

Given a pair of FEATURE microenvironments (A and B) derived from two different sites, we calculate an adjusted Tanimoto coefficient based on the presence/absence of similar properties. We compute a single standard deviation (STD) for each of the 480 properties across a random set of FEATURE microenvironments (see section "Background calculation). Two microenvironments have a "similar property" if they differ by less than one STD for the given property. Given A and B, c is the number of "similar properties"; a and b are the numbers of non-zero properties in A and B, respectively; the denominator is the total number of unique properties that are non-zero in A or B or both (a+b−c); then the Tanimoto similarity is as follows: .

Background calculation {#s4c}
----------------------

We make observations of the background distributions of Tc scores between microenvironments from different sites. We compile a dataset of 1160 sites from a non-redundant set of 3D structures in PDB using these filters: (1) structures were solved using X-ray diffraction at resolutions higher than 2.0 Angstrom; (2) no two structures have greater than 40% sequence identity; (3) specifically bound small molecule ligands have more than the heavy atoms. The binding residues are defined as those having any atom within 6 Angstroms of the ligand molecules, resulting in a total of 22008 microenvironments. There are 242 possible types of pairs between 22 types of microenvironments centered on 20 residues types (two centers for residue W and Y), but not all of these are likely to be matched. For computational efficiency, we group residues by physical properties in order to avoid comparisons that are unlikely to yield high similarity scores. The comparisons are limited to pairs of microenvironments that fall within the same groups: positively charged (R H K), negatively charged (D E), polar (S T Q N W1 Y1), non-polar (A C G I L M P V) and aromatic (W2 Y2 F). This produces 72 microenvironment-pairs (out of the 200 possible) that we check for high similarity scores. Given each microenvironment-pair, we derive Tc scores from the above dataset and fit these score into normal distribution.

Comparing two binding sites {#s4d}
---------------------------

Given the FEATURE microenvironments from two binding sites, we exhaustively calculate the raw Tc scores of all permissible microenvironment-pairs. We then normalize the Tc scores using the background frequency [@pcbi.1002326-Subbiah1]:

Tc~0~ is the value at which S(Tc) is zero.

In practice, Tc~0~ is the Tc score at the mode on the fitted cumulative distribution function (CDF) of a given type of microenvironment-pair (See Background calculation). The normalized value, S(Tc), measures the similarity between two microenvironments and is thus the **microenvironment similarity score**.

We search for the mutual best-scoring microenvironment-pairs between two binding sites and assign alignment to such pairs using an cutoff of S(Tc) less than −0.3. For example, between site A (microenvironments A1, A2, A3, A4 and A5) and site B (microenvironments B1, B2, B3, B4 and B5), we align A1 to B1 only when (1) S(Tc) between A1 and B1 is smaller than those between A1 and B1, B2, B4 B5, also smaller than those between B1 and A2, A3, A4, A5; (2) S(Tc) between A1 and B1 is smaller than −0.3. The sum of all aligned microenvironment-pairs is the overall similarity score between two binding sites, and is termed the binding site similarity score. We can vary the cutoff for S(Tc) to change the precision and resolution of the comparison.

Benchmark datasets {#s4e}
------------------

We perform two sets of benchmark. The first benchmark identifies pairs of proteins that bind adenine-containing ligands, using two datasets [@pcbi.1002326-Xie1] provided by Bourne group from USCD. Dataset I consists of 247 sites from non-redundant protein structures known to bind an adenine-containing ligand (ATP, ADP, NAD, FAD, SAH and SAM); Dataset II consists of 101 cavities from non-redundant protein structures believed not to bind an adenine-containing moiety. From Dataset I, we have 30381 pairs of sites that both bind adenine-containing ligands. Between Dataset I and II, we have 24947 control pairs of sites in which one site binds adenine-containing ligands and the other does not.

The second benchmark recognizes FAD binding sites from a large-scale dataset. A dataset consisting of 6958 druggable binding sites (Dataset-6958) was derived from scPDB entries [@pcbi.1002326-Kellenberger1] by filtering out PDB entries where atom coordinates of binding residues were incomplete. The binding sites were defined by including all the protein residues with at least one atom within 6 Angstrom of any ligand atom. Dataset-6958 includes a total of 249 FAD-binding proteins.

Predicting inhibitor-binding profiles of kinases {#s4f}
------------------------------------------------

We derive a subset of 984 binding sites from Dataset-6958, including proteins classified in eight different EC families: EC 2.7.1, EC 2.7.2, EC 2.7.3, EC 2.7.4, EC 2.7.10, EC 2.7.11, EC 2.7.12 and EC 2.7.13. A total of 203 sites bind to ATP, ANP or ADP. The other 781 structures bind to 633 other ligands.

Using the 203 sites involved in binding ATP, ANP or ADP, we generate pairs of binding sites from functionally and structurally distant kinases by applying two rules: (1) two kinases are from different EC sub-subgroups; (2) the identity of structural alignment by MAMMOTH [@pcbi.1002326-Ortiz1] between the two kinases is not higher than 30%. This results in 6058 pairs of sites that bind to ATP, ANP or ADP.

We perform validation using experimental data from CHEMBL [@pcbi.1002326-Overington1] and Ambit panel [@pcbi.1002326-Karaman1]. Ambit panel contains binding assays between 37 inhibitors (21 tyrosine kinase inhibitors, 15 serine-threonine kinase inhibitors, and 1 lipid kinase inhibitor), which are classified according to the targets for which they were originally developed, and 317 human kinases (287 different human protein kinases, three lipid kinases and 27 disease-relevant mutant variants). Staurosporine is a non-selective kinase inhibitor and is therefore removed from the validation dataset.

We use two standards to identify candidate inhibitors from Ambit panel: a stringent cutoff of Kd\<1 uM and a ratio of off-target to primary target affinities (Kd off-target/Kd primary target) \<100. Our local database downloaded from CHEMBL includes binding assays between 3199 protein domains and 541,137 compounds. It is a collection of assays from a variety of experimental studies and therefore the standards applied to Ambit Panel are not applicable to CHEMBL data. We first filter out data with confidence level less than seven. We then use either (1) a cutoff of IC50 less than 1 uM or (2) a cutoff of Kd less than 1 uM or (3) inhibition level higher than 90% at 1 uM as an indication of inhibition.

From the 6058 pairs of divergent kinases, we first search for pairs for which experimental data, from CHEMBL or Ambit, are available for both kinases. Given such a pair, if at least one compound/inhibitor satisfies the standards above for both kinases, the pair shares ligand binding and is a "positive-pair"; otherwise this pair is a "negative-pair".
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